Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary...

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiovascular Surgery

Background:

• Left main coronary artery disease (LMCAD) is a high-risk subset of obstructive coronary artery disease affecting the myocardium.
• Coronary artery bypass grafting (CABG) has historically been the gold standard for LMCAD treatment.
• Percutaneous coronary intervention (PCI) has evolved significantly, becoming a viable alternative.

Purpose of the Study:

• To review the evolution of LMCAD treatments.
• To compare the clinical evidence for state-of-the-art PCI versus CABG for LMCAD.
• To address unmet issues in LMCAD revascularization strategies.

Main Methods:

• Review of randomized clinical trials, meta-analyses, and observational registries.
• Analysis of comparative long-term survival data for PCI and CABG.
• Focus on advancements in PCI technology, pharmacotherapy, and surgical techniques.

Main Results:

• Recent studies indicate comparable long-term survival rates between PCI and CABG for LMCAD.
• Tradeoffs exist between the early and late risk-benefit profiles of each treatment modality.
• PCI is established as a safe and reasonable option for complex LMCAD.

Conclusions:

• Both PCI and CABG are effective revascularization strategies for LMCAD.
• The choice between PCI and CABG requires careful consideration of individual patient factors and risk-benefit profiles.
• Further research is needed to optimize LMCAD management and revascularization strategies.